Video
Christopher Topoleski, Director of Federal Legislative Affairs for ASHP, talks about the ongoing legislative actions aimed at addressing rising medication costs in the drug industry.
Christopher Topoleski, Director of Federal Legislative Affairs for ASHP, talks about the ongoing legislative actions aimed at addressing rising medication costs in the drug industry.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria